Bhopal (Madhya Pradesh): In the aftermath of the Coldriff syrup controversy, which claimed at least 16 children’s lives in Chhindwara and Betul, authorities conducted random checks of other syrups.

Two more syrups failed tests and were immediately banned for being of Non Standard Quality (NSQ).

The first NSQ syrup is Ambroxol HCL, Guaiphenesine Terbutaline Sulphate and Menthol Syrup (Batch LSL25160, Mfg Jan 25, Exp Dec 26), manufactured by Shape Pharma Pvt Ltd, Surendranagar, Rajkot, Gujarat. It contains 0.616% DEG.

The second is Bromohexin Hydrochloride Terbutaline Sulphate, Guaiphenesine and Menthol Syrup (Batch RO1GL2523, Mfg Jan 1, 2025), manufactured by Rednonex Pharmaceuticals Pvt Ltd, Bavla, Ahmedabad.It contains 1.342% DEG,

Health authorities have begun seizing stocks of both

See Full Page